- Home >
- Life Sciences >
- Pharmaceutical >
- Over-The-Counter Drug >
Generics and Ingredient sector in Western europe and Eastern europe
Generics and Ingredient sector in Western europe and Eastern europe
Related industries
Main tags
More
MOST UP TO DATE REPORTS ABOUT «generics»
Generics and Pharmaceuticals trends in Usa
- October 2009
- 390 pages
« ... The company? Or ?The issuer? Unless the context otherwise indicates or implies, refers to glenmark generics limited and its subsidiaries on a consold basis, as described in this draft red ... »
Industries : Pharmaceutical, Over-The-Counter Drug | Countries : USA
Generic drugs outlook in Usa
- August 2009
- 12 pages
« ... Pharmaceutical companies with monopoly protections that allow them to market some drugs without com- petition by less costly generics. We examined availability of certain drugs in guatemala and found that cafta ... »
Industries : Over-The-Counter Drug | Countries : USA
Generics and Spirit trends in Usa
- July 2009
- 6 pages
« ... The generic trial program is a standard part of the prescription drug benefit. B-2494/2887-08 if taking to treat consider these generics in go.Excellusbcbs.Com/generics if taking to treat ... »
Industries : Spirits, Over-The-Counter Drug | Countries : USA
Generics trends in Western europe
- April 2009
- 24 pages
« ... Discounts not steep enough and not as effective as generic competition ?No solution to patent barriers to the development of fdcs and new formulations e.G. For children ? ?Voluntary? Licenses ?Restrictions ... »
Industries : Over-The-Counter Drug | Countries : France
Generics sector in Usa
- March 2009
- 5 pages
« ... For the generic medicines industry supplied in hard-copy format ? Receive most weeks free-of-charge as part of their subscription. Contacting if you need any information ... »
Industries : Over-The-Counter Drug | Countries : USA
« ... And emerging generic markets ? Operating income growing faster than sales ? Sandoz ? The leading high quality gx company ? Globally top-ranked with high share of frontrunner positions ? Successful in changing ... »
« ... Of 2007 launches ? Cefdinir launch in us ? Only 365 days to complete development for active ingredient and finished dosage form ? Inhouse production of active ingredient through a non-infringing form ... »
« ... Involved in the development of new pharmaceutical products; unexpected clinical trial results, including additional analysis of existing clinical data or unexpected new clinical data; unexpected regulatory ... »
reportlinker.com © Copyright 2010. All rights reserved